Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Effectiveness and Safety of Pericapsular Nerve Group (PENG) Block in Hip Fracture Patients on Antithrombotic Therapy: A Randomized Controlled Trial

NCT06582667 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

NCT NCT06582667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06582667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Effectiveness and Safety of Pericapsular Nerve Group (PENG) Block in Hip Fracture Patients on Antithrombotic Therapy: A Randomized Controlled Trial
Lead sponsor
Alexandria University
Phase
Not applicable
Overall status
Unknown status
Start date
September 17, 2024
Completion date
April 17, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antithrombotic therapy, hip fracture, peng block